These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35968873)

  • 1. Impact of Respiratory Syncytial Virus on Child, Caregiver, and Family Quality of Life in the United States: Systematic Literature Review and Analysis.
    Glaser EL; Hariharan D; Bowser DM; Gervasio RM; Rowlands KR; Buckley L; Nelson CB; Shepard DS
    J Infect Dis; 2022 Aug; 226(Suppl 2):S236-S245. PubMed ID: 35968873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life burden on United States infants and caregivers due to lower respiratory tract infection and adjusting for selective testing: Pilot prospective observational study.
    Hariharan D; Kumar VSS; Glaser EL; Crown WH; Wolf ZA; Fisher KA; Wood CT; Malcolm WF; Nelson CB; Shepard DS
    Health Sci Rep; 2023 Jun; 6(6):e1338. PubMed ID: 37334041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe.
    Mao Z; Li X; Dacosta-Urbieta A; Billard MN; Wildenbeest J; Korsten K; Martinón-Torres F; Heikkinen T; Cunningham S; Snape MD; Robinson H; Pollard AJ; Postma M; Dervaux B; Hens N; Bont L; Bilcke J; Beutels P;
    Vaccine; 2023 Apr; 41(16):2707-2715. PubMed ID: 36941154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year.
    Suh M; Movva N; Bylsma LC; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S195-S212. PubMed ID: 35968876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost and health-related quality of life for children hospitalized with respiratory syncytial virus in Central China.
    Ren L; Cui L; Wang Q; Gao L; Xu M; Wang M; Wu Q; Guo J; Lin L; Liang Y; Liu N; Cheng Y; Yang J; Yu H
    Influenza Other Respir Viruses; 2023 Aug; 17(8):e13180. PubMed ID: 37640557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis.
    Bowser DM; Rowlands KR; Hariharan D; Gervasio RM; Buckley L; Halasa-Rappel Y; Glaser EL; Nelson CB; Shepard DS
    J Infect Dis; 2022 Aug; 226(Suppl 2):S225-S235. PubMed ID: 35968875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review.
    Bylsma LC; Suh M; Movva N; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S267-S281. PubMed ID: 35968871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
    van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
    J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.
    Nokes DJ; Okiro EA; Ngama M; Ochola R; White LJ; Scott PD; English M; Cane PA; Medley GF
    Clin Infect Dis; 2008 Jan; 46(1):50-7. PubMed ID: 18171213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery.
    Leidy NK; Margolis MK; Marcin JP; Flynn JA; Frankel LR; Johnson S; Langkamp D; Simoes EA
    Pediatrics; 2005 Jun; 115(6):1536-46. PubMed ID: 15930214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates for quality of life loss due to Respiratory Syncytial Virus.
    Hodgson D; Atkins KE; Baguelin M; Panovska-Griffiths J; Thorrington D; van Hoek AJ; Zhao H; Fragaszy E; Hayward AC; Pebody R
    Influenza Other Respir Viruses; 2020 Jan; 14(1):19-27. PubMed ID: 31625688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age.
    Movva N; Suh M; Bylsma LC; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S213-S224. PubMed ID: 35968874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory Syncytial Virus Disease: Immunoprophylaxis Policy Review and Public Health Concerns in Preterm and Young Infants.
    Staebler S; Blake S
    Policy Polit Nurs Pract; 2021 Feb; 22(1):41-50. PubMed ID: 33050785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ResQ Family: Respiratory Syncytial Virus (RSV) Infection in Infants and Quality of Life of Families-Study Protocol of a Multi-Country Family Cohort Study.
    Trautmannsberger I; Bösl S; Tischer C; Kostenzer J; Mader S; Zimmermann LJI; The ResQ Family Study Group
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis.
    McLaughlin JM; Khan F; Schmitt HJ; Agosti Y; Jodar L; Simões EAF; Swerdlow DL
    J Infect Dis; 2022 Mar; 225(6):1100-1111. PubMed ID: 33346360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus acute respiratory infection-associated hospitalizations in preterm Mexican infants: A cohort study.
    Benítez-Guerra D; Piña-Flores C; Zamora-López M; Escalante-Padrón F; Lima-Rogel V; González-Ortiz AM; Guevara-Tovar M; Bernal-Silva S; Benito-Cruz B; Castillo-Martínez F; Martínez-Rodríguez LE; Ramírez-Ojeda V; Tello-Martínez N; Lomelí-Valdez R; Salto-Quintana J; Cadena-Mota S; Noyola DE
    Influenza Other Respir Viruses; 2020 Mar; 14(2):182-188. PubMed ID: 31917902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States.
    Herring WL; Zhang Y; Shinde V; Stoddard J; Talbird SE; Rosen B
    Vaccine; 2022 Jan; 40(3):483-493. PubMed ID: 34933763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.